David Glidden, PhD

Phone: 415-514-8009
UCSF Box: 0560
Email: [email protected]
UCSF Profile

Project	Sponsor	Location(s)	Topics	Start	End
Statistical methods for clinical trials of novel PrEP agents	NIH National Institute of Allergy and Infectious Disease	United States	HIV/AIDS, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development	9/24/18	8/31/22
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis	NIH National Institute of Allergy and Infectious Disease	United States	HIV/AIDS, Pharmacology and Drug Treatment	1/1/16	12/31/18
Chemoprophylaxis for HIV Prevention: Analysis of Bone and Metabolic Effects	NIH National Institute of Allergy and Infectious Disease	United States	HIV/AIDS	6/19/15	5/31/18
Chemoprophylaxis for HIV Prevention in Men Expansion Study [II]	FHI 360	South Africa; Thailand; Brazil; Ecuador; Peru	HIV/AIDS	2/1/13	11/30/14
Chemoprophylaxis for HIV Prevention in Men Expansion Study [I]	J. David Gladstone Institutes	South Africa; Thailand; Brazil; Ecuador; Peru	HIV/AIDS	2/1/12	1/31/13
Chemoprophylaxis for HIV Prevention in Men Expansion Study [III]	J. David Gladstone Institutes	South Africa; Thailand; Brazil; Ecuador; Peru	HIV/AIDS	9/1/07	12/31/11
Failure Time Methods for Family Disease Studies	NIH National Heart, Lung, and Blood Institute	United States; Australia	Cardiovascular Disease	4/1/01	3/31/06

Global Research Projects